HIGHLIGHTS
- who: ISRN Oncology and collaborators from the of Pathology, Haartman Institute and HUSLAB, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland have published the paper: High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing’s Sarcoma Family of Tumour Patients, in the Journal: (JOURNAL) of 24/07/2011
- what: Our results suggest that even in cancers of noninflammatory origin like ESFTs an macrophage-enriched inflammatory microenvironment that distinguishes the tumour site from normal adjacent tissue is present at the time of clinically evident disease.
-
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.